PAM
CNST

Panagora Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Panagora Asset Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-57,865
Closed -$1.96M – 2838
2021
Q2 		$1.96M Sell
57,865
-1,271
-2% -$32.4K 0.01% 717
2021
Q1 		$1.38M Buy
59,136
+46,785
+379% +$1.42M 0.01% 884
2020
Q4 		$356K Buy
12,351
+11,433
+1,245% +$288K ﹤0.01% 1358
2020
Q3 		$19K Sell
918
-1,100
-55% -$26.9K ﹤0.01% 2229
2020
Q2 		$61K Buy
+2,018
New +$72.7K ﹤0.01% 1927

Panagora Asset Management's CNST Position: Q3 2021 in Review

Panagora Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 57,865 shares — an estimated $1.96M sold.

Panagora Asset Management first reported a position in CNST in Q2 2020 and held it in 5 quarters. The position peaked at $1.96M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Panagora Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 57,865 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.96M.
  • Panagora Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
  • Panagora Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $1.96M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.